Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's disease.
AL101 (GSK4527226) 是一种可提高前粒蛋白水平的单克隆抗体,其开发有望成为治疗阿尔茨海默病的一种潜在疗法
期刊:Alzheimers Research & Therapy
影响因子:7.6
doi:10.1186/s13195-025-01817-4
Budda Balasubrahmanyam, Mitra Ananya, Park Lovingly, Long Hua, Kurnellas Michael, Bien-Ly Nga, Estacio William, Burgess Brady, Chao Grace, Schwabe Tina, Paul Robert, Kenkare-Mitra Sara, Rosenthal Arnon